RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD)

CUSIP: 75955J402

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock ($.001 par value)
Shares outstanding
74,702,121
Total 13F shares
8,399,225
Share change
-4,005,636
Total reported value
$4,362,564
Put/Call ratio
13%
Price per share
$0.52
Number of holders
48
Value change
-$9,886,723
Number of buys
15
Number of sells
48

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FRANKLIN RESOURCES INC
13F
Company
1.7%
1,302,151
$4,362,206 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
1.7%
1,256,705
$4,071,724 30 Sep 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
1.6%
1,186,452
$3,842,000 30 Sep 2024
13F
PARSONS CAPITAL MANAGEMENT INC/RI
13F
Company
1.3%
1,002,695
$3,248,732 30 Sep 2024
13F
Palo Alto Investors LP
13F
Company
0.98%
732,400
$2,372,976 30 Sep 2024
13F
Deep Track Capital, LP
13F
Company
0.9%
674,833
$2,186,459 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
0.76%
567,880
$1,839,931 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.75%
561,826
$1,820,316 30 Sep 2024
13F
Vestal Point Capital, LP
13F
Company
0.66%
490,000
$1,587,600 30 Sep 2024
13F
Opaleye Management Inc.
13F
Company
0.64%
480,000
$1,555,200 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.42%
315,059
$1,020,791 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.41%
304,502
$986,791 30 Sep 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.32%
242,500
$785,700 30 Sep 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.3%
224,846
$728,501 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.28%
206,658
$669,571 30 Sep 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.26%
191,315
$619,861 30 Sep 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.24%
181,077
$586,689 30 Sep 2024
13F
Shay Capital LLC
13F
Company
0.23%
175,547
$568,772 30 Sep 2024
13F
RBF Capital, LLC
13F
Company
0.22%
165,474
$536,136 30 Sep 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.21%
157,672
$510,857 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
0.2%
145,999
$473,037 30 Sep 2024
13F
UBS Group AG
13F
Company
0.17%
126,385
$409,488 30 Sep 2024
13F
FMR LLC
13F
Company
0.16%
116,544
$377,603 30 Sep 2024
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.15%
108,412
$351,000 30 Sep 2024
13F
MGO ONE SEVEN LLC
13F
Company
0.13%
100,000
$324,000 30 Sep 2024
13F
STATE STREET CORP
13F
Company
0.13%
99,235
$321,521 30 Sep 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.13%
98,945
$320,582 30 Sep 2024
13F
FEDERATED HERMES, INC.
13F
Company
0.12%
87,425
$283,257 30 Sep 2024
13F
apricus wealth, LLC
13F
Company
0.11%
78,962
$255,837 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.1%
74,716
$242,080 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.1%
73,404
$237,933 30 Sep 2024
13F
AdvisorShares Investments LLC
13F
Company
0.09%
68,528
$222,031 30 Sep 2024
13F
ExodusPoint Capital Management, LP
13F
Company
0.09%
68,000
$220,000 30 Sep 2024
13F
CITIGROUP INC
13F
Company
0.08%
62,951
$203,962 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.07%
52,846
$171,221 30 Sep 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.07%
50,825
$164,673 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
0.07%
50,570
$163,847 30 Sep 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.06%
41,730
$135,205 30 Sep 2024
13F
Ikarian Capital, LLC
13F
Company
0.05%
40,369
$130,795 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.05%
37,877
$122,721 30 Sep 2024
13F
SEI INVESTMENTS CO
13F
Company
0.05%
36,320
$117,675 30 Sep 2024
13F
World Investment Advisors
13F
Company
0.04%
32,684
$105,896 30 Sep 2024
13F
AlTi Global, Inc.
13F
Company
0.04%
31,975
$103,599 30 Sep 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.04%
31,554
$102,235 30 Sep 2024
13F
HORIZON KINETICS ASSET MANAGEMENT LLC
13F
Company
0.04%
30,000
$97,200 30 Sep 2024
13F
Pegasus Asset Management, Inc.
13F
Company
0.04%
26,958
$87,344 30 Sep 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.03%
25,888
$83,877 30 Sep 2024
13F
Tortoise Investment Management, LLC
13F
Company
0.03%
21,676
$70,230 30 Sep 2024
13F
Sargent Investment Group, LLC
13F
Company
0.03%
21,460
$69,530 30 Sep 2024
13F
ROTHSCHILD INVESTMENT LLC
13F
Company
0.03%
20,000
$64,800 30 Sep 2024
13F

Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) as of Q4 2024

As of 31 Dec 2024, RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,399,225 shares. The largest 10 holders included FRANKLIN RESOURCES INC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, BlackRock, Inc., Palo Alto Investors LP, GEODE CAPITAL MANAGEMENT, LLC, DEUTSCHE BANK AG\, UBS Group AG, AdvisorShares Investments LLC, and BANK OF AMERICA CORP /DE/. This page lists 48 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
69
Q4 2024 holders
48
Holder diff
-21
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.